Clinical Trials · NCT00262470

Treatment of Orthostatic Intolerance

Active Not RecruitingPhase 1/Phase 2Octreotide (Investigational)
Phase
Phase 1/Phase 2
Recruitment status
Active Not Recruiting
Sponsor
Satish R. Raj
Enrollment
150
Start date
Apr 1997
Locations
1 site, United States
Primary endpoint
Increase in heart rate with standing
View Octreotide compound reference